Global HIV & AIDS statistics — Fact sheet

Global HIV statistics

  • 39 millones de personas viven con el vih en 2022.
  • 13 millones de personas se han infectado recientemente con el vih en 2022.
  • 630 000 [480 000–880 000] people died from AIDS-related illnesses in 2022.
  • 298 millones de personas accedieron a la terapia antiretroviral en 2022.
  • 856 millones [648-113.0] de personas se han infectado con el vih y 40,4 millones [329,51.3 millones] million] people have died from AIDS-related illnesses since the start of the epidemic.

People living with HIV

  • En 2022, 39 millones de personas viven con el vih.
    • 375,000 [318,000-436,000] adultos (15 años o más).
    • 15 millones de niños (de 0 a 14 años).
    • 53% of all people living with HIV were women and girls.
  • 86% [73– >98%] of all people living with HIV knew their HIV status in 2022.

People living with HIV accessing antiretroviral therapy

  • At the end of December 2022, 298 millones de personas (76% [65-89%] de todas las personas que viven con el vih) reciben terapia antiretroviral, Hasta 77 millones en 2010.
    • 77% [65–90%] of adults aged 15 years and older had access to treatment; however, just 57% [44–78%] of children aged 0–14 years had access.
    • 82% [69–95%] of women aged 15 years and older had access to treatment; however, just 72% [60–84%] of men aged 15 years and older had access.
    • 82% [64–98%] of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2022.
  • 92 millones de personas que viven con el vih no han tenido acceso al tratamiento antiretroviral en 2022.

New HIV infections

  • New HIV infections have been reduced by 59% since the peak in 1995.
    • En 2022, 13 millones de personas se infectarán recientemente con el vih, Comparadas con 32 millones de personas en 1995.
    • Women and girls accounted for 46% of all new infections in 2022.
  • Since 2010, new HIV infections have declined by 38%, De 21 millones [16 — 28 millones] a 13 millones [10 — 17 millones] en 2022.
  • Since 2010, new HIV infections among children have declined by 58%, from 310 000 [210 000–490 000] in 2010 to 130 000 [90 000–210 000] in 2022.

AIDS-related deaths

  • AIDS-related deaths have been reduced by 69% since the peak in 2004 and by 51% since 2010.
  • In 2022, around 630 000 [480 000–880 000] people died from AIDS-related illnesses worldwide, En comparación con los 20 millones de [15 — 28 millones] de personas en 2004 y los 13 millones de [97 — 18 millones] en 2010.
  • AIDS-related mortality has declined by 55% among women and girls and by 47% among men and boys since 2010.

Women and girls

  • Globally 46% of all new HIV infections were among women and girls in 2022.
  • In sub-Saharan Africa, adolescent girls and young women accounted for more than 77% of new infections among young people aged 15-24 years in 2022.
  • In sub-Saharan Africa adolescent girls and young women (aged 15-24 years) in were more than three times as likely to acquire HIV than their male peers in 2022. 
  • Every week, 4000 adolescent girls and young women aged 15–24 years became infected with HIV globally in 2022. 3100 of these infections occurred in sub-Saharan Africa.
  • Only about 42% of districts with high HIV incidence in sub-Saharan Africa had dedicated HIV prevention programmes for adolescent girls and young women in 2021.

Key populations

  • Globally, Median HIV prevalencia entre la población adulta (edad 15-49) era 0.7%. Sin embargo, la prevalencia median fue mayor entre key populations:
    • 2.5% entre trabajadores sexuales
    • 7,5% entre hombres homosexuales y otros hombres que tienen sexo con hombres
    • 5.0% entre la gente que inyecta drogas
    • 10.3% entre personas transgénero
    • 1,4% entre personas en prisiones.

Testing and treatment targets (95–95–95)

  • In 2022, 86% [73– >98%] of all people living with HIV knew their HIV status. Among people who knew their status, 89% [75– >98%] were accessing treatment. And among people accessing treatment, 93% [79– >98%] were virally suppressed.
  • Among all people living with HIV, 86% [73– >98%] knew their status, 76% [65–89%] were accessing treatment and 71% [60–83%] were virally suppressed in 2022.
  • Five countries— Botswana, Eswatini, Rwanda, the United Republic of Tanzania, and Zimbabwe had achieved the 95-95-95 targets by 2022.

Funding

  • Un total de 20,8 mil millones de dólares (2019 US$) se dispuso para programas contra el vih en países de bajos y medios ingresos. 2022-2,6% menos que en 2021 y menos de US$29.3 mil millones necesarios por 2025.
  • Around 60% of resources available in 2022 were sourced domestically, compared with around 50% in 2010.
  • The reduction in resources available for HIV in 2022 is due to declines in both international and domestic funding. The US$8,3 mil millones de fondos externos para el vih en 2022 eran 3% menos que en 2021. Al mismo tiempo, domestic funding is diminishing.
  • Bilateral funding from the United States Government constituted 58% of all international assistance for HIV, while disbursements from the Global Fund to Fight AIDS, Tuberculosis and Malaria accounted for about 29%. Other international donors contributed the remainder, Pero esa participación es considerada desde aproximadamente US$3 mil millones en 2010 hasta US$1.2 mil millones en 2022, a 61% decrease.
  • In 2022, there was an estimated 90% funding gap for HIV prevention programmes among people from key populations, compared with the funding needed by 2025.

Download the full version to view regional statistics, global and regional data

HIV estimates with uncertainty bounds 1990-Present

Download spreadsheet (updated 31 Aug 2023)

Additional resources

Regional and thematic fact sheets

UNAIDS data 2023

Tuberculosis fact sheet